Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'D-3 RECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 287 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ito, Y; Horie, S; Shindo, Y
      A novel [2+2] photodimerization of N-[(E)-3,4-methylenedioxycinnamoyl]dopamine in the solid state

      ORGANIC LETTERS
    2. Bezard, E; Brotchie, JM; Gross, CE
      Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

      NATURE REVIEWS NEUROSCIENCE
    3. Gimenez-Llort, L; Ahlbom, E; Dare, E; Vahter, M; Ogren, SO; Ceccatelli, S
      Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    4. Rybakowski, JK; Borkowska, A; Czerski, PM; Hauser, J
      Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects

      MOLECULAR PSYCHIATRY
    5. Govoni, S; Racchi, M; Masoero, E; Zamboni, M; Ferini-Strambi, L
      Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly

      MOLECULAR PSYCHIATRY
    6. Carvey, PM; McGuire, SO; Ling, ZD
      Neuroprotective effects of D3 dopamine receptor agonists

      PARKINSONISM & RELATED DISORDERS
    7. Guttman, M; Jaskolka, J
      The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?

      PARKINSONISM & RELATED DISORDERS
    8. Amenta, F; Ricci, A; Rossodivita, I; Avola, R; Tayebati, SK
      The dopaminergic system in hypertension

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    9. Sotnikova, TD; Gainetdinov, RR; Grekhova, TV; Rayevsky, KS
      Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study)

      PHARMACOLOGICAL RESEARCH
    10. Lehmann, T; Hubner, H; Gmeiner, P
      Dopaminergic 7-aminotetrahydroindolizines: Ex-chiral pool synthesis and preferential D3 receptor binding

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    11. Dziedzicka-Wasylewska, M; Ferrari, F; Johnson, RD; Mierau, J; Rogoz, Z; Skuza, G; Sokoloff, P
      Mechanisms of action of pramipexole: Effects on receptors

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    12. Betancur, C; Lepee-Lorgeoux, I; Cazillis, M; Accili, D; Fuchs, S; Rostene, W
      Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D-3 receptor deficient mice

      NEUROPSYCHOPHARMACOLOGY
    13. Verlinden, L; Verstuyf, A; Quack, M; Van Camp, M; Van Etten, E; De Clercq, P; Vandewalle, M; Carlberg, C; Bouillon, R
      Interaction of two novel 14-epivitamin D-3 analogs with vitamin D-3 receptor-retinoid X receptor heterodimers on vitamin D-3 responsive elements

      JOURNAL OF BONE AND MINERAL RESEARCH
    14. Levant, B; McCarson, KE
      D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function

      NEUROSCIENCE LETTERS
    15. Whitfield, GK; Remus, LS; Jurutka, PW; Zitzer, H; Oza, AK; Dang, HTL; Haussler, CA; Galligan, MA; Thatcher, ML; Dominguez, CE; Haussler, MR
      Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    16. Liao, DL; Yeh, YC; Chen, HM; Chen, H; Hong, CJ; Tsai, SJ
      Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

      NEUROPSYCHOBIOLOGY
    17. Hillefors, M; von Euler, G
      Pharmacology of [H-3]R(+)-7-OH-DPAT binding in the rat caudate-putamen

      NEUROCHEMISTRY INTERNATIONAL
    18. Deransart, C; Landwehrmeyer, GB; Feuerstein, TJ; Lucking, CH
      Up-regulation of D3 dopaminergic receptor mRNA in the core of the nucleus accumbens accompanies the development of seizures in a genetic model of absence-epilepsy in the rat

      MOLECULAR BRAIN RESEARCH
    19. Gut-Fayand, A; Dervaux, A; Olie, JP; Loo, H; Poirier, MF; Krebs, MO
      Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity

      PSYCHIATRY RESEARCH
    20. Richtand, NM; Woods, SC; Berger, SP; Strakowski, SM
      D3 dopamine receptor, behavioral sensitization, and psychosis

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    21. Mattingly, BA; Caudill, A; Abel, M
      Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    22. Zuch, CL; Cory-Slechta, DA
      Stimulus properties of 7-OH-DPAT versus auto- and postsynaptic receptor-specific doses of quinpirole

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    23. Blednov, YA; Stoffel, M; Chang, SR; Harris, RA
      GIRK2 deficient mice - Evidence for hyperactivity and reduced anxiety

      PHYSIOLOGY & BEHAVIOR
    24. Audinot, V; Newman-Tancredi, A; Millan, MJ
      Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms

      NEUROPHARMACOLOGY
    25. Scarselli, M; Novi, F; Schallmach, E; Ling, RW; Baragli, A; Colzi, A; Griffon, N; Corsini, GU; Sokoloff, P; Levenson, R; Vogel, Z; Maggio, R
      D-2/D-3 dopamine receptor heterodimers exhibit unique functional properties

      JOURNAL OF BIOLOGICAL CHEMISTRY
    26. Walbert, T; Jirikowski, GF; Prufer, K
      Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat

      HORMONE AND METABOLIC RESEARCH
    27. Curran, MP; Perry, CM
      Amisulpride - A review of its use in the management of schizophrenia

      DRUGS
    28. Horikawa, T; Hirokawa, Y; Kato, S
      A practical preparation of methyl 2-methoxy-6-methylaminopyridine-3-carboxylate from 2,6-dichloro-3-trifluoromethylpyridine

      CHEMICAL & PHARMACEUTICAL BULLETIN
    29. Weber, B; Schlicker, E; Sokoloff, P; Stark, H
      Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    30. Yoshikawa, T; Yoshida, N; Oka, M
      The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D-2, D-3 and 5-HT3 receptors antagonist

      BRITISH JOURNAL OF PHARMACOLOGY
    31. Wade, TV; Rothblat, DS; Schneider, JS
      Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism

      BRAIN RESEARCH
    32. Lopes-Machado, EZ; Duarte, FAM
      Localization of genes modulating the predisposition to schizophrenia: a revision

      GENETICS AND MOLECULAR BIOLOGY
    33. Ishiguro, H; Okuyama, Y; Toru, M; Arinami, T
      Mutation and association analysis of the 5 ' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia

      MOLECULAR PSYCHIATRY

    34. Tetrahydroisoquinololine derivatives as modulators of dopamine D-3 receptors

      EXPERT OPINION ON THERAPEUTIC PATENTS
    35. Hubble, JP
      Pre-clinical studies of pramipexole: clinical relevance

      EUROPEAN JOURNAL OF NEUROLOGY
    36. Dutta, AK; Neisewander, J; Fuchs, R; Reith, MEA
      Synthesis and characterization of novel derivatives of 2-aminotetralins: Development of highly selective derivatives for the D3 receptor

      MEDICINAL CHEMISTRY RESEARCH
    37. Swamy, N; Addo, JK; Ray, R
      Development of an affinity-driven cross-linker: Isolation of a vitamin D receptor associated factor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    38. Einsiedel, J; Thomas, C; Hubner, H; Gmeiner, P
      Phenyloxazoles and phenylthiazoles as benzamide bioisosteres: Synthesis and dopamine receptor binding profiles

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    39. McKenna, NJ; O'Malley, BW
      From ligand to response: generating diversity in nuclear receptor coregulator function

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    40. Carta, AR; Gerfen, CR; Steiner, H
      Cocaine effects on gene regulation in the striatum and behavior: increasedsensitivity in D3 dopamine receptor-deficient mice

      NEUROREPORT
    41. Joyce, JN; Yoshimoto, K; Ueda, S
      The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system

      NEUROREPORT
    42. Perachon, S; Betancur, C; Pilon, C; Rostene, W; Schwartz, JC; Sokoloff, P
      Role of dopamine D-3 receptors in thermoregulation: a reappraisal

      NEUROREPORT
    43. Dringenberg, HC; Wightman, M; Beninger, RJ
      The effects of amphetamine and raclopride on food transport: possible relation to defensive behavior in rats

      BEHAVIOURAL PHARMACOLOGY
    44. Scatton, B; Sanger, DJ
      Pharmacological and molecular targets in the search for novel antipsychotics

      BEHAVIOURAL PHARMACOLOGY
    45. Bordet, R; Ridray, S; Schwartz, JC; Sokoloff, P
      Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    46. Campbell, MJ; Gombart, AF; Kwok, SH; Park, S; Koeffler, HP
      The anti-proliferative effects of 1 alpha,25(OH)(2)D-3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression

      ONCOGENE
    47. Petronis, A
      The genes for major psychosis: Aberrant sequence or regulation?

      NEUROPSYCHOPHARMACOLOGY
    48. Kroncke, KD; Carlberg, C
      Inactivation of zinc finger transcription factors provides a mechanism fora gene regulatory role of nitric oxide

      FASEB JOURNAL
    49. Jurutka, PW; Remus, LS; Whitfield, GK; Thompson, PD; Hsieh, JC; Zitzer, H; Tavakkoli, P; Galligan, MA; Dang, HTL; Haussler, CA; Haussler, MR
      The polymorphic N terminus in human vitamin D receptor isoforms influencestranscriptional activity by modulating interaction with transcription factor IIB

      MOLECULAR ENDOCRINOLOGY
    50. Videbaek, C; Toska, K; Scheideler, MA; Paulson, OB; Knudsen, GM
      SPECT tracer [I-123]IBZM has similar affinity to dopamine D2 and D3 receptors

      SYNAPSE
    51. Canales, JJ; Iversen, SD
      Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors

      SYNAPSE
    52. Hirsch, EC
      Nigrostriatal system plasticity in Parkinson's disease: Effect of dopaminergic denervation and treatment

      ANNALS OF NEUROLOGY
    53. Langer, O; Gulyas, B; Sandell, J; Laszlovszky, I; Kiss, B; Domany, G; Acs, T; Farde, L; Halldin, C
      Radiochemical labelling of the dopamine D-3 receptor ligand RGH-1756

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    54. Barbanti, P; Fabbrini, G; Ricci, A; Pascali, MP; Bronzetti, E; Amenta, F; Lenzi, GL; Cerbo, R
      Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes

      CEPHALALGIA
    55. Boulay, D; Depoortere, R; Perrault, G; Sanger, DJ
      Decreased locomotor activity after microinjection of dopamine D-2/D-3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: A D-3 receptor mediated effect?

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    56. Rachez, C; Gamble, M; Chang, CPB; Atkins, GB; Lazar, MA; Freedman, LP
      The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes

      MOLECULAR AND CELLULAR BIOLOGY
    57. Diaz, J; Pilon, C; Le Foll, B; Gros, C; Triller, A; Schwartz, JC; Sokoloff, P
      Dopamine D-3 receptors expressed by all mesencephalic dopamine neurons

      JOURNAL OF NEUROSCIENCE
    58. Anton, B; Calva, JC; Valdez, A; Acevedo, R; Morales, A; Medecigo, M; Leff, P
      Neurobiology of addiction: Neuroanatomical, neurochemical, molecular and genetic aspects of morphine and cocaine addiction. Part II

      SALUD MENTAL
    59. Ellinwood, EH; King, GR; Davidson, C; Lee, TH
      The dopamine D-2/D-3 antagonist DS121 potentiates the effect of cocaine onlocomotion and reduces tolerance in cocaine tolerant rats

      BEHAVIOURAL BRAIN RESEARCH
    60. Kremer, I; Rietschel, M; Dobrusin, M; Mujaheed, M; Murad, I; Blanaru, M; Bannoura, I; Muller, DJ; Schulze, TG; Reshef, A; Gathas, S; Schwab, S; Wildenauer, D; Bachner-Melman, R; Belmaker, RH; Maier, W; Ebstein, RP
      No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population

      AMERICAN JOURNAL OF MEDICAL GENETICS
    61. Barr, CL; Wigg, KG; Wu, J; Zai, C; Bloom, S; Tannock, R; Roberts, W; Malone, M; Schachar, R; Kennedy, JL
      Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder

      AMERICAN JOURNAL OF MEDICAL GENETICS
    62. Shang, YF; Hu, X; DiRenzo, J; Lazar, MA; Brown, M
      Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

      CELL
    63. Depoortere, R; Perrault, G; Sanger, DJ
      The D-3 antagonist PNU-99194A potentiates the discriminative cue produced by the D-3 agonist 7-OH-DPAT

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    64. Kaasinen, V; Nagren, K; Hietala, J; Oikonen, V; Vilkman, H; Farde, L; Halldin, C; Rinne, JO
      Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease

      NEUROLOGY
    65. Gilbert, DL; Sethuraman, G; Sine, L; Peters, S; Salle, FR
      Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial

      NEUROLOGY
    66. Gilliland, SL; Alper, RH
      Characterization of dopaminergic compounds at hD(2short), hD(4.2) and hD(4.7) receptors in agonist-stimulated [S-35]GTP gamma S binding assays

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    67. Stanwood, GD; Artymyshyn, RP; Kung, MP; Kung, HF; Lucki, I; McGonigle, P
      Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [I-125]7-OH-PIPAT: Evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    68. Stanwood, GD; Lucki, I; McGonigle, P
      Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    69. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    70. Millan, MJ; Dekeyne, A; Rivet, JM; Dubuffet, T; Lavielle, G; Brocco, M
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    71. Quack, M; Carlberg, C
      Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements

      JOURNAL OF MOLECULAR BIOLOGY
    72. Chen, SC; Cui, JF; Nakamura, K; Ribeiro, RCJ; West, BL; Gardner, DG
      Coactivator-vitamin D receptor interactions mediate inhibition of the atrial natriuretic peptide promoter

      JOURNAL OF BIOLOGICAL CHEMISTRY
    73. Ahonen, MH; Zhuang, YH; Aine, R; Ylikomi, T; Tuohimaa, P
      Androgen receptor and vitamin D receptor in human ovarian cancer: Growth stimulation and inhibition by ligands

      INTERNATIONAL JOURNAL OF CANCER
    74. von Euler, M; Pham, TM; Hillefors, M; Bjelke, B; Henriksson, B; von Euler, G
      Inhalation of low concentrations of toluene induces persistent effects on a learning retention task, beam-walk performance, and cerebrocortical size in the rat

      EXPERIMENTAL NEUROLOGY
    75. Kawanishi, Y; Tachikawa, H; Suzuki, T
      Pharmacogenomics and schizophrenia

      EUROPEAN JOURNAL OF PHARMACOLOGY
    76. Karasinska, JM; George, SR; El-Ghundi, M; Fletcher, PJ; O'Dowd, BF
      Modification of dopamine D-1 receptor knockout phenotype in mice lacking both dopamine D-1 and D-3 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    77. Cussac, D; Newman-Tancredi, A; Sezgin, L; Millan, MJ
      The novel antagonist, S33084, and CR218,231 interact selectively with cloned and native, rat dopamine D-3 receptors as compared with native, rat dopamine D-2 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    78. Heijtz, RD; Ogren, SO; Fuxe, K
      Ontogeny of the motor inhibitory role of dopamine D-3 receptor subtype in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    79. Boulay, D; Depoortere, R; Oblin, A; Sanger, DJ; Schoemaker, H; Perrault, G
      Haloperidol-induced catalepsy is absent in dopamine D-2 but maintained in dopamine D-3 receptor knock-out mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    80. Kaichi, Y; Nonaka, R; Hagino, Y; Watanabe, M
      Dopamine D-3 receptor binding by D-3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    81. Muhlbauer, B; Kuster, E; Luippold, G
      Dopamine D-3 receptors in the rat kidney: role in physiology and pathophysiology

      ACTA PHYSIOLOGICA SCANDINAVICA
    82. Szumlinski, KK; Goodwill, AM; Szechtman, H
      Locomotor sensitization to quinpirole in rats: effects of drug abstinence and sex

      PSYCHOPHARMACOLOGY
    83. Cook, CD; Barrett, AC; Syvanthong, C; Picker, MJ
      Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat

      PSYCHOPHARMACOLOGY
    84. Cook, CD; Barrett, AC; Syvanthong, C; Picker, MJ
      The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphinetolerance but not physical dependence in rats

      PSYCHOPHARMACOLOGY
    85. Smith, AD; Smith, DL; Zigmond, MJ; Amalric, M; Koob, GF
      Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm

      PSYCHOPHARMACOLOGY
    86. Kirov, G; Jones, I; McCandless, F; Craddock, N; Owen, MJ
      Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5

      MOLECULAR PSYCHIATRY
    87. Craig, TA; Benson, LM; Tomlinson, AJ; Veenstra, TD; Naylor, S; Kumar, R
      Analysis of transcription complexes and effects of ligands by microelectrospray ionization mass spectrometry

      NATURE BIOTECHNOLOGY
    88. Zea-Ponce, Y; Laruelle, M
      Protein precipitation: An expedient procedure for the routine analysis of the plasma metabolites of [I-123]IBZM

      NUCLEAR MEDICINE AND BIOLOGY
    89. Honda, K; Riehl, J; Mignot, E; Nishino, S
      Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep (vol 10, pg 3111, 1999)

      NEUROREPORT
    90. Menalled, LB; Dziewczapolski, G; Garcia, MC; Rubinstein, M; Gershanik, OS
      D-3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion

      NEUROREPORT
    91. Honda, K; Riehl, J; Mignot, E; Nishino, S
      Dopamine D-3 agonists into the substratia nigra aggravates cataplexy but does not modify sleep

      NEUROREPORT
    92. Scharfetter, J; Chaudhry, HR; Hornik, K; Fuchs, K; Sieghart, W; Kasper, S; Aschauer, HN
      Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    93. Levant, B; Garimelli, B; Shafer, RA; Merchant, KM
      Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride

      NEUROPSYCHOPHARMACOLOGY
    94. Basile, VS; Masellis, M; Badri, F; Paterson, AD; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, F; Kennedy, JL
      Association of the MscI polymorphism of the dopamine D3 receptor gene withtardive dyskinesia in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    95. GUREVICH EV; JOYCE JN
      DISTRIBUTION OF DOPAMINE D-3 RECEPTOR-EXPRESSING NEURONS IN THE HUMANFOREBRAIN - COMPARISON WITH D-2 RECEPTOR-EXPRESSING NEURONS

      Neuropsychopharmacology
    96. Prufer, K; Veenstra, TD; Jirikowski, GF; Kumar, R
      Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord

      JOURNAL OF CHEMICAL NEUROANATOMY
    97. Tremblay, M; Rouillard, C; Levesque, D
      Dopamine D-3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain

      SYNAPSE
    98. Xu, M; Koeltzow, TE; Cooper, DC; Tonegawa, S; White, FJ
      Dopamine D3 receptor mutant and wild-type mice exhibit identical responsesto putative D3 receptor-selective agonists and antagonists

      SYNAPSE
    99. Ukai, M; Tamoto, H; Tanaka, T; Kameyama, T
      Characterization of the dopamine D-3 receptor agonist R(+)-7-hydroxy-N, N-di-n-propyl-2-aminotetralin-induced hypo- and hypermotility in mice

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    100. Toell, A; Degenhardt, S; Grabensee, B; Carlberg, C
      Inhibitory effect of uremic solutions on protein-DNA-complex formation of the vitamin D receptor and other members of the nuclear receptor superfamily

      JOURNAL OF CELLULAR BIOCHEMISTRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 00:45:32